If you are looking for a place to start your PMED Due Diligence use this post to help you. Feel free to share:
1.Tech Mahindra will be the reseller for their marijuana and alcohol impairment technology as soon as the 3500 person clinical trial is completed mid-July. Tech Mahindra is in 91 countries and has 151,000 employees giving PMED instant global scale.
2. Hindalco will deploy the impairment technology to all of their plants (36,000 employees) as soon as the Corporate test pilot phase is completed at their major aluminum facility in India also mid July. This will be a multi million $ major contract. We know results of the study are successful as it was the request of the Unit Head of Hindalco who rushed into the pilot before the clinical study was completed. He's also used other AI from these guys before as it has helped Hindalco become more precise in the their operations saving them money.
3. Once the Clinical study is completed the results will be published in peer reviewed journals which means that courts can start to reference them also by mid-July. This is important for law enforcement agencies around the world to use PMED technology for enforcement of marijuana laws. PMED will actually be defining the standard for impairment. Currently speaking with one US State's law enforcement on this.
4. Currently in 14 Indian Max Hospitals in a pilot study which will almost certainly turn into a paying contract by mid summer.
Three Ontario hospitals also on deck to employ this same Covid19 screening technology as we have DR. ALEXANDER D. BARRON who has expertise in infectious disease and screening and works in 3 different Ontario hospital emergency departments: Norfolk General, St. Mary’s General and Grand River Hospital.
5. Juiceworks & PMED JV will sell Covid 19 screening technology & hardware / screening booths to all of North America and the world, happening now.
6. Mr. Raval, head of Microsoft AI Business Development was holdings meetings with PMED's COO in order to help solidify "big market" orders for end users of Covid 19 screening needs who had infrastructure in place and to possibly add a heavy-weight reseller for just the technology... just as Tech Mahindra is going to do for the impairment technology. This result would leave sales forces deployed for all technologies and PMED with a small burn rate and handful of employees to simply run the core administrative operations.
The COO's exact words on t.v. yesterday were as follows..... “demand has been phenomenal "
He is not a person to exaggerate.
7. PMED's ramping up its marketing campaign with news articles out everywhere including Blogto (643,000 followers) plus a COO interview on Toronto's Global Radio, a Toronto City TV interview and next week a BNN interview.
8. PMED has no debt, $1.7M in the bank and a monthly burn rate of $45k / month. Directors and Officers work for shares and have the right to cash in 10 million shares at .15 each which will bring in another $1.5M
PMED is doing everything right.
I hate to put all my eggs in one basket but I'm finding it difficult to find any other stock with as much potential, that will rise as much as this one likely will in the quickest amount of time.
https://www.predictmedix.com/